Health Supervision for Children and Adolescents With Down Syndrome

This clinical report is designed to assist the pediatrician in caring for the child, adolescent, and family in whom a diagnosis of Down syndrome has been confirmed by chromosome analysis or suspected by prenatal screening. Although a pediatrician’s initial contact with the child is usually during infancy, occasionally the pregnant woman who has been given a prenatal diagnosis of Down syndrome will be referred for review of the condition and genetic counseling; this report offers guidance for this situation, as well. Age-specific guidance for the clinician is provided in Supplemental Fig 1.Pediatricians play an important role in the care of children and adolescents with Down syndrome and their families. Down syndrome is the most common chromosomal cause of intellectual disability, and there has been a significant improvement in quality of life for affected people. Awareness of the issues important to affected children, adolescents, and their caregivers can make a great difference in outcomes across the lifespan.Children with Down syndrome may have many cooccurring medical conditions and cognitive impairment because of the presence of extra genetic material from chromosome 21 (Table 1).1,2 Although the phenotype is variable, there typically are multiple features that enable the experienced clinician to suspect the diagnosis. Among the more common physical findings are hypotonia, small brachycephalic head, epicanthal folds, flat nasal bridge, upward-slanting palpebral fissures, Brushfield spots, small mouth, small ears, excessive skin at the nape of the neck, single transverse palmar crease, short fifth finger with clinodactyly, and wide spacing between the first and second toes, often with a deep plantar groove. The degree of cognitive impairment is variable and may be mild (IQ of 50–70), usually is moderate (IQ of 35–50), or occasionally is severe (IQ of 20–35).Medical conditions common in children with Down syndrome include hearing loss (75%), obstructive sleep apnea (50%–79%), otitis media (50%–70%), eye problems (60%–80%), including cataracts (<1%–3%),3 nasolacrimal duct obstruction (3%–36%), and strabismus and severe refractive errors (36%–80%), congenital heart defects (50%), neurologic dysfunction (1%–13%), gastrointestinal atresia (12%), hip dislocation and hip abnormalities (2%–8%),4,5 symptomatic atlantoaxial instability (1%–2%),6,7 thyroid disease (24%–50%)2,8 and, less commonly, transient abnormal myelopoiesis (4%–10%) and later leukemia (1%), autoimmune diseases,2,8–10 including Hashimoto thyroiditis (13%–39%), with incidence dependent on age, celiac disease (1%–5%), Hirschsprung disease (<1%),3 and autism (7%–19%).11,12People with Down syndrome often function more effectively in social situations than would be predicted based on cognitive assessment results, unless there is presence of cooccurring autism. Although the level of social–emotional functioning may vary, these skills may be improved with early intervention and therapy through early adulthood.In ∼96% of children with Down syndrome, the condition is sporadic because of nonfamilial trisomy 21, in which there are 47 chromosomes with the presence of a free extra chromosome 21. In ∼3% to 4% of people with the Down syndrome phenotype, the extra chromosomal material is the result of an unbalanced translocation between chromosome 21 and another acrocentric chromosome, usually chromosome 14 or 21. Approximately three-quarters of these unbalanced translocations are de novo, and the remainder result from translocation inherited from a parent. If the child has a translocation, the parents should be offered a karyotype to determine whether the translocation is familial or de novo. In the remaining 1% to 2% of people with the Down syndrome phenotype, a mix of 2 cell lines is present: 1 normal and the other with trisomy 21. This condition is called mosaicism. People with mosaicism may be more mildly affected than people with complete trisomy 21 or translocation chromosome 21, but this is not always the case, and their condition may include any of the associated medical problems and may be indistinguishable from trisomy 21. The chance of recurrence for families with an affected child depends on many factors and vary greatly, from 1% in most families to 100% in some circumstances. Table 2 describes the different chromosomal characteristics of Down syndrome.Formal counseling by a clinical geneticist or genetic counselor is recommended for all families.Several areas require ongoing assessment throughout childhood and should be reviewed at every health supervision visit and at least annually. These areas include: personal support available to family;participation in a family-centered medical home;age-specific Down syndrome-related medical and developmental conditions;financial and medical support programs and long-term financial planning for which the child and family may be eligible;injury and abuse prevention, with special consideration of developmental skills and intellectual ability; andnutrition and activity to maintain appropriate weight.The American College of Obstetricians and Gynecologists recommends that all pregnant women, regardless of age or risk status, be offered the option of screening and diagnostic testing for Down syndrome.17,18A wide variety of screening test options exist in the first and second trimester using maternal serum and ultrasonography. Each offers varying levels of sensitivity and specificity. No 1 screening test is superior to other screening tests in all characteristics. In recent years, noninvasive prenatal testing by cell-free DNA (cfDNA) has become available and is the most sensitive method for screening for Down syndrome. cfDNA screening for Down syndrome is significantly more sensitive and specific than conventional screening methods, with a 2017 meta-analysis reporting a detection rate of 99.7%, with a false-positive rate of 0.04% in singleton pregnancies.19 cfDNA uses a maternal blood sample to analyze free-floating small fragments of DNA from the placenta. Because cfDNA is from the placenta and not directly from the fetus, it is a screening test and not diagnostic. cfDNA analysis can be performed as early as 9 to 10 weeks’ gestation depending on the laboratory, and a high-risk result from cfDNA would require confirmation by diagnostic testing with chorionic villus sampling (CVS) or amniocentesis. Screening for trisomy 21 by cfDNA in twin pregnancies can be performed, but total number of reported cases is small.20Other screening tests for Down syndrome include first-trimester screening, which incorporates maternal age, nuchal translucency ultrasonography, and measurement of maternal serum β human chorionic gonadotropin and pregnancy-associated plasma protein A. Second-trimester screening is available for patients who first seek medical care in the second trimester or in locations where first-trimester screening is not available. The second-trimester serum screening, often called the quad screen, incorporates maternal age risk with measurement of maternal serum β human chorionic gonadotropin, unconjugated estriol, α-fetoprotein, and inhibin concentrations. The detection rate of Down syndrome by first-trimester screening is 82% to 87%, by second trimester screening is 80%, and by combined first- and second-trimester screening (referred to as integrated screening) is ∼95%. These screening tests are reported to have a 5% false-positive rate.21–24Ultrasonography is an additional screening tool for Down syndrome because structural changes, including congenital heart defects, increased nuchal skin fold, “double bubble” sign suggestive of duodenal atresia, ventriculomegaly, and short–long bones, may be identified by prenatal imaging. Although ultrasonography is an additional screening tool, it is not diagnostic for Down syndrome.Diagnostic testing for Down syndrome includes CVS or amniocentesis. CVS has the benefit of being performed earlier in pregnancy, between 10 and 14 completed weeks’ gestation. A placental sample is obtained either transabdominally or transcervically, depending on provider preference and placental location. Amniocentesis is a transabdominal procedure to remove a sample of amniotic fluid performed after 15 weeks’ gestational age. Risk for procedure-related loss of pregnancy from CVS or amniocentesis is comparable in recent studies when performed by providers with expertise, 0.22% for amniocentesis and 0.11% for CVS.25,26Pediatricians may be asked to counsel a family whose fetus has been identified with or is at increased chance of having Down syndrome. Families may have a great number of questions during any pregnancy and especially when the child will have Down syndrome. They may have received counseling from a certified genetic counselor, a clinical geneticist, maternal–fetal medicine specialist, obstetrician, or developmental specialist. In addition, parents may have received information and support from a family-led organization such as Parent to Parent USA, a local Down syndrome group, a national Down syndrome organization, social media, or possibly an Internet site with inaccurate information. Pediatricians who often have a previous relationship with the family may be the natural source of support for and guidance in the context of the medical home. The clinician should be prepared to respond to questions, review information the family has received, and assist in the decision-making process.27 When asked, the pediatrician should discuss the following topics with the family: The prenatal laboratory studies and any confirmatory testing that led to the diagnosis and any fetal imaging studies that have been or will be performed. Many families find it important to have the diagnosis confirmed before they can consider what it will mean to their infant and their family.Families benefit from hearing a fair and balanced perspective, including the many positive outcomes of children with Down syndrome and their effects on the family. Families usually have questions about prognosis and phenotypic manifestations, including the wide range of variability seen in infants and children with Down syndrome. The prenatal visit is a good time to offer a connection to a peer-to-peer organization for support (see Family Resources).Discuss any additional studies performed that may refine the estimation of the prognosis (eg, fetal echocardiography, ultrasonography for gastrointestinal tract malformations). Consultation with an appropriate medical subspecialist, such as a pediatric cardiologist or a pediatric surgeon, may occur prenatally if abnormal findings are detected.Discuss currently available treatments and interventions. Families need to hear that they are not alone and that there are supports and services for them after the infant is born. Discuss early intervention resources, parent-support programs, and any appropriate future treatments.Discuss extended life expectancy that has increased from 30 years in 1973 to 60 years in 2002. This increase has resulted from improved medical care, educational options, and enhanced social adaptation. Potential complications and adverse effects, costs and financial supports available, and other challenges associated with comprehensive management and care should also be discussed. The pediatrician can explain that they will be supported best in the context of a patient-centered medical home.There are many issues for the family learning that their child will have Down syndrome to consider. These issues should be discussed using a nondirective approach. In cases of prenatal diagnosis, this may include discussion of pregnancy continuation or termination, raising the child in the family, foster care placement, and adoption.28The mechanism for occurrence of Down syndrome in the fetus and the potential recurrence rate for the family, as provided by genetic counseling, should be shared. Discuss availability of genetic counseling or meeting with a genetics professional.As the pregnancy continues, the pediatrician may: Develop a plan for delivery and neonatal care with the obstetrician and the family. As the pregnancy progresses, additional studies should be performed if available, if recommended by medical subspecialists and/or if desired by the family. These studies (eg, detection of a complex heart defect by fetal echocardiography) may help direct development of a management plan and improve outcome for the mother and infant.29Offer parent-to-parent contact and information about local and national support organizations because communication with experienced parents is often a very helpful resource for caregiver decision-making.Offer referral to a clinical geneticist or genetic counselor for a more extended discussion of clinical outcomes and variability, recurrence rates, future reproductive options, and evaluation of the risks for other family members.It is recognized that the medical needs of newborn infants with Down syndrome vary, and the timing of each intervention depends on the infant’s needs, but that it is important that all interventions are addressed and that careful transfer of care occurs at the time of discharge from the hospital.The first step in evaluating a newborn infant for trisomy 21 is a careful review of the family history and prenatal information, to include: results of prenatal chromosome studies, if performed; andfamily history of previous children born with trisomy 21 or developmental differences or pregnancies that ended in miscarriage. (These may be significant clues that a family may carry a balanced translocation that predisposes them to having children with trisomy 21.)For children who have had the diagnosis made prenatally, a formal copy of the chromosome report from an amniocentesis or CVS should be obtained. This report allows the clinician to confirm the diagnosis, review the results with the family, and add the formal diagnosis to the child’s medical record. If the results of prenatal testing are not available or if cfDNA alone was performed, a sample of cord or peripheral blood should be obtained for postnatal karyotype to confirm the diagnosis and rule out a chromosome translocation.A physical examination is the most sensitive test in the first 24 hours of life to diagnose trisomy 21 in an infant. If the clinician believes that criteria for Down syndrome are present on physical examination, then a blood sample should be sent for a karyotype. The clinician should alert the laboratory and request rapid results. A study that uses fluorescent in situ hybridization (FISH) technology, in addition, should be available within 24 to 48 hours, if necessary, to facilitate diagnosis and parent counseling. A FISH study, however, can only indicate that an extra copy of chromosome 21 is present and does not determine the presence or absence of a translocation. Therefore, a positive FISH result should be confirmed by a karyotype to identify translocations that may have implications for further reproductive counseling for the parents and possibly other family members. A chromosomal microarray analysis is not appropriate because it will not differentiate trisomy 21 caused by nondisjunction versus an unbalanced translocation.When delivering a diagnosis of Trisomy 21 (Table 3): the mother should be allowed to recover from the immediate delivery of the infant and have her partner or support person present before the diagnosis is given;the information should be relayed in a private setting by the physicians involved, optimally by the primary care provider for the infant and the delivering physician30; andit is recommended that hospitals coordinate the delivery of the information and offer a private hospital room pending confirmation of the diagnosis.When providing information about Down syndrome to families, the physician should first congratulate parents on the birth of their infant. Obstetricians and pediatricians should coordinate their messaging and inform parents of their suspicion immediately, in a private setting, and when appropriate, with both parents together. Physicians should use their experience and expertise in providing support and guidance for families. Clinicians should ensure a balanced approach that reflects the variability and broad range of current outcomes, rather than their personal opinions or experience, give current printed materials, and offer access to other families who have children with Down syndrome and support organizations if locally available. It is important that clinicians be cognizant of the realities and possibilities for people with Down syndrome to have healthy, productive lives.30The laboratory diagnosis of Down syndrome should be confirmed, and the karyotype should be reviewed with the parents when the final result is available. The specific findings should be discussed with both parents whenever possible, including the potential clinical manifestations associated with the syndrome. These topics should be reviewed again at a subsequent meeting. Families should be offered referral for genetic counseling if it was not conducted prenatally.Newborn care is often provided in a hospital setting by a physician who will not be the primary care pediatrician. If the physician providing newborn care will not be the primary care pediatrician, he or she should ensure that there is a smooth transition by transferring medical records and ensuring that an early newborn follow-up appointment is scheduled.Characteristics attributable to Down syndrome, as well as those that are familial, should be discussed.Follow Bright Futures schedule or more frequently if indicated. Obtain a history and perform a physical examination.Monitor weight and follow weight-for-length trends at each health care visit. Review the infant’s growth and plot it on the Down syndrome-specific charts for weight, length, weight for length, and head circumference (available at www.cdc.gov).57,58Review feeding at every health supervision visit, ensure adequate iron intake, and inquire about any changes in respiratory symptoms with feeding (see “Health Supervision From Birth to 1 Month” for discussion).Review the previous hearing evaluation (brainstem auditory evoked response [BAER] or otoacoustic emission). If the infant passed the newborn screening study, rescreen at 6 months of age for confirmation.Risk of otitis media with effusion is 50% to 75%.43 Middle-ear disease should be treated immediately when diagnosed. As soon as a clear ear is established, a diagnostic BAER should be performed to accurately establish hearing status.In children with stenotic canals in which the tympanic membranes cannot be seen, refer to an otolaryngologist as soon as possible for examination under an office microscope. Interval ear examinations should be performed by the otolaryngologist every 3 to 6 months until the tympanic membrane can be visualized by the pediatrician and tympanometry can be performed reliably.43A behavioral audiogram may be attempted at 1 year of age, but many children will not be able to complete the study. If unable to complete a behavioral audiogram, additional testing by BAER should be performed at 1 year.Ear anomalies also place child at risk for sensorineural hearing loss and vestibular problems that may affect balance, making the thorough audiologic assessment additionally important.59–61Within the first 6 months of life, refer to a pediatric ophthalmologist or ophthalmologist with expertise and experience with infants with disabilities to evaluate for strabismus, cataracts, nasolacrimal duct obstruction, refractive errors, glaucoma, and nystagmus.16,62–64Check the infant’s vision at each visit and use developmentally appropriate subjective and objective criteria. If lacrimal duct obstruction is present, refer for evaluation for surgical repair of drainage system if not resolved by 9 to 12 months of age.65Verify results of newborn thyroid-function screen if not previously reviewed. Because of increased risk of acquired thyroid disease, repeat measurement of TSH at 6 and 12 months of age and then annually (see Health Supervision From Birth to 1 Month for discussion).Monitor infants with cardiac defects at all well-child visits, typically ventricular or atrioventricular septal defects that cause intracardiac left-to-right shunts, for symptoms and signs of congestive heart failure as pulmonary vascular resistance decreases and pulmonary blood flow increases. Tachypnea, feeding difficulties, and poor weight gain may indicate heart failure. Medical management, including nutritional support, may be required until the infant is in optimal condition to undergo cardiac surgery to repair the defects to limit the potential for development of pulmonary hypertension and associated complications.66 Infants and children with Down syndrome are also at increased risk of pulmonary hypertension even in the absence of intracardiac structural defects. Close coordination of care between the primary care physician and the subspecialist is important for these infants.Anemia/iron deficiency: Obtain a complete blood cell count (CBC) with differential and either (1) a combination of ferritin and C-reactive protein (CRP), or (2) a combination of serum iron and total iron-binding capacity (TIBC), beginning at 1 year of age and annually thereafter.Children with Down syndrome have been shown to have a similar risk for iron-deficiency anemia as the typical population, but it may be missed because of macrocytosis.67 Iron insufficiency may precede iron-deficiency anemia and also can have long-term neurologic effects.67,68 Macrocytosis, with increased erythrocyte mean corpuscular volume, is present in up to one-third of patients with Down syndrome.69 Thus, a low mean corpuscular volume is not a useful screen for the diagnoses of iron deficiency/insufficiency, lead toxicity, or thalassemia in children with Down syndrome. Screening by hemoglobin concentration identifies iron deficiency anemia but misses iron deficiency/iron insufficiency. Using the CBC parameter of an elevated relative distribution width with ferritin or transferrin saturation or serum iron divided by TIBC leads to 100% sensitivity in identifying iron insufficiency, iron deficiency, or anemia. Serum ferritin concentration is an acute-phase reactant and is not useful if inflammation is present or CRP is elevated: subsequent evaluation with iron concentration and TIBC may be needed to confirm diagnosis. Although not unique to children with Down syndrome, low ferritin is also associated with sleep problems, and iron deficiency may be considered in differentials for children with sleep difficulty.70 A physician may prescribe iron supplementation for children with sleep problems and a ferritin concentration <50 μg/L.70,71Pediatricians should be alert to the signs and symptoms of leukemia discussed in Health Supervision From Birth to 1 Month and obtain an extra CBC with differential if symptoms occur. Children with Down syndrome who develop acute leukemia can be treated successfully with similar acute lymphocytic leukemia therapy or de-intensified acute myeloid leukemia chemotherapy regimens with outcomes superior to other children.72,73Assess with complete neurologic history and examination and consult with neurology as needed for signs of neurologic dysfunction that may occur. Children with Down syndrome have an increased risk of seizures, including infantile spasms (1%–13%)74,75 and other conditions, including moyamoya disease76,77 and benign movement disorders such as shuddering.Administer immunizations, including influenza vaccine, respiratory syncytial virus vaccine for infants with cooccurring qualifying conditions, and other vaccines recommended for all children, unless there are specific contraindications.78Assess for dermatologic findings and advise parents that xerosis (dry skin) and cutis marmorata are common.At least once during the first 6 months of life, discuss with family symptoms of obstructive sleep apnea, including heavy breathing, snoring, uncommon sleep positions, frequent night awakening, daytime sleepiness, apneic pauses, and behavior problems that could be associated with poor sleep. Refer to a physician with expertise in pediatric sleep disorders for examination and further evaluation of a possible sleep disorder if any of the previously mentioned symptoms occur.79,80At each well-child visit, discuss with parents the importance of maintaining the cervical spine in a neutral position during any anesthetic, surgical, or radiographic procedure to minimize the risk of spinal cord injury and review the signs and symptoms of myelopathy, which include asymmetry of movement, weakness, and, on examination, increased deep tendon reflexes. Obtain history and carefully perform a physical examination, paying attention for myelopathic signs and symptoms.Follow Bright Futures schedule or more frequently if indicated.Follow Bright Futures schedule or more frequently as indicated. Obtain a history and perform a physical examination.Monitor weight and follow BMI trends at each health care visit. Review the child’s growth and plot it on the Down syndrome-specific charts for weight, height, and head circumference.120 These charts should be used in conjunction with the Down syndrome-specific BMI chart for children up to age 10 and with the BMI chart from the Centers for Disease Control and Prevention, which is a better indicator of excess adiposity for children with Down syndrome over the age of 10.58Review feeding. Ask about any changes in respiratory symptoms with feeding and ensure adequate iron intake (see Health Supervision From Birth to 1 Month for discussion).Emphasize healthy diet and lifestyle for preventing obesity.Obtain annual ear-specific audiologic evaluation (see Health Supervision From 1 Month to 1 Year for discussion). If middle ear disease occurs, obtain developmentally appropriate hearing evaluation after treatment.Obtain ophthalmologic evaluation by photoscreening, if available, at every health supervision visit or by a pediatric ophthalmologist or ophthalmologist with expertise in children with disabilities every 2 years63,85 (see Health Supervision From 1 Month to 1 Year for discussion).Measure TSH annually; the risk of hypothyroidism increases with age (See “Health Supervision From 1 to 5 Years” for discussion). Measure TSH every 6 months if antithyroid antibodies have been detected.Individualize cardiology follow-up on the basis of history of cardiac defects.Obtain a CBC and either (1) a combination of ferritin and CRP, or (2) a combination of serum iron and TIBC, beginning at 1 year of age and annually thereafter (see Health Supervision From 1 Month to 1 Year for discussion).A physician may prescribe iron supplementation for children with sleep problems and a ferritin concentration <50 μg/L (see Health Supervision From 1 to 5 Years for discussion).Palpate testes at each health supervision visit (see Health Supervision From 1 to 5 Years for discussion).For children on a diet that contains gluten, review for symptoms potentially related to celiac disease at every health maintenance visit and evaluate if indicated (see Health Supervision From 1 to 5 Years for discussion).At each well-child visit, discuss with family the importance of universal precautions for protection of the cervical spine during any anesthetic, surgical, or radiographic procedure. Perform careful history and physical examination, with attention to myelopathic signs and symptoms. Caregivers should also be instructed to contact their physician immediately for new onset of symptoms of myelopathy (see Health Supervision From 1 to 5 Years for discussion).Discuss skin, hair, and scalp care at each preventive health care visit and refer to dermatologist if needed (see Health Supervision From 1 to 5 Years for discussion).Encourage caregivers to promote self-help skills and assume developmentally appropriate responsibilities in the home. Monitor for behavior problems that interfere with function in the home, community, or school. Attention problems, attention-deficit/hyperactivity disorder, obsessive-compulsive behaviors, noncompliant behavior, and wandering off are some of the common behavior concerns reported. Psychiatric disorders affecting typically developing children may also occur. Evaluate for medical problems that can be associated with behavior changes, including thyroid abnormalities, celiac disease, sleep-disordered breathing, gastroesophageal reflux, and constipation. Intervention strategies depend on the child’s age, the severity of the problem, and the setting in which the problem occurs. When symptoms interfere with daily activities, refer to community treatment programs, psychosocial services for consultative care, or behavioral specialists experienced in working with children with special needs. Refer patients who have chronic behavioral problems or manifest acute deterioration in function for specialized evaluation and intervention112,113,121 (see Health Supervision From 1 to 5 Years for discussion).Be aware that children with Down syndrome are frequently more sensitive to certain medications. Before initiating medication for behavior management, the process should be discussed between the primary care physician and specialists involved in the child’s care. Although there has been little research to directly address the use of psychotropic medications among children with Down syndrome, anecdotal reports indicate that these children may differ in their response to medications. Experience has led to the recommendation to start medications at the lowest recommended dose and increase or decrease the dose according to the child’s response.122Inquire regarding symptoms of neurologic dysfunction, including seizures, and perform a neurologic examination.Discuss symptoms related to sleep-disordered breathing at every well-child visit, including snoring, restless sleep, daytime sleepiness, nighttime awakening, behavior problems, and abnormal sleep position. Refer to a physician with expertise in pediatric sleep, otolaryngologist, or a pediatric sleep medicine specialist any child with signs or symptoms of sleep-disordered breathing or abnormal sleep-study results. Children with sleep problems and a ferritin concentration <50 μg/L may benefit from iron supplementation.70,71 Discuss obesity as a risk factor of sleep apnea and review need to implement healthy diet and activity in affected patients (see Health Supervision From 1 to 5 Years for discussion).Follow Bright Futures schedule or more frequently as indicated.Many issues related to the development and health of people with Down syndrome remain to be evaluated, and research agendas for addressing both public health and basic science topics have been developed. Knowledge in several topics of great importance to the care of children with Down syndrome could be enhanced through population-based research. A rigorous, evidence-based review of screening and treatment of atlantoaxial instability, for example, is needed, and continuing research is critical for directing the care for optimal outcomes of people with Down syndrome.1,139–141Marilyn J. Bull, MD, FAAP Tracy Trotter, MD, FAAP Stephanie L. Santoro, MD, FAAP Celanie Christensen, MD, MS, FAAP Randall W. Grout, MD, MS, FAAPLeah W. Burke, MD, FAAP; ChairpersonTracy L. Trotter, MD, FAAP, Co-Chairperson Susan A. Berry, MD, FAAP Timothy A. Geleske, MD, FAAP Ingrid Holm, MD, FAAP Robert J. Hopkin, MD, FAAP Wendy J. Introne, MD, FAAP Michael J. Lyons, MD, FAAP Danielle C. Monteil, MD, FAAP Angela Scheuerle, MD, FAAP Joan M. Stoler, MD, FAAP Samantha A. Vergano, MD, FAAPEmily Chen, MD, PhD, FAAP, Co-Chairperson Rizwan Hamid, MD, PhD, FAAP Tracy L. Trotter, MD, FAAP, Co-ChairpersonStephen M. Downs, MD, MS, FAAP Randall W. Grout, MD, MS, FAAPChristopher Cunniff, MD, PhD, FAAP; American College of Medical Genetics Melissa A. Parisi, MD, PhD, FAAP; Eunice Kennedy Shriver National Institute of Child Health and Human Development Steven J. Ralston, MD; American College of Obstetricians and Gynecologists Joan A. Scott, MS, CGC; Health Resources and Services Administration, Maternal and Child Health Bureau Stuart K. Shapira, MD, PhD; Centers for Disease Control and PreventionPaul Spire